Next Article in Journal
In Vitro Assessment of Biofilm Production, Antibacterial Resistance of Staphylococcus aureus, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter spp. Obtained from Tonsillar Crypts of Healthy Adults
Previous Article in Journal
Conversion of Escherichia coli into Mixotrophic CO2 Assimilation with Malate and Hydrogen Based on Recombinant Expression of 2-Oxoglutarate:Ferredoxin Oxidoreductase Using Adaptive Laboratory Evolution
Previous Article in Special Issue
Features of Mycobacterium bovis Complete Genomes Belonging to 5 Different Lineages
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Microorganisms
Volume 11
Issue 2
10.3390/microorganisms11020255
microorganisms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Genetic Diversity and Primary Drug Resistance of Mycobacterium tuberculosis Beijing Genotype Strains in Northwestern Russia

by
Anna Vyazovaya
1,*,
Alena Gerasimova
1,
Regina Mudarisova
1,
Daria Terentieva
1,
Natalia Solovieva
2,
Viacheslav Zhuravlev
2 and
Igor Mokrousov
1,3,*
1
Laboratory of Molecular Epidemiology and Evolutionary Genetics, St. Petersburg Pasteur Institute, 197101 St. Petersburg, Russia
2
St. Petersburg Research Institute of Phthisiopulmonology, 191036 St. Petersburg, Russia
3
Henan International Joint Laboratory of Children’s Infectious Diseases, Children’s Hospital Affiliated to Zhengzhou University, Zhengzhou 450018, China
*
Authors to whom correspondence should be addressed.
Microorganisms 2023, 11(2), 255; https://doi.org/10.3390/microorganisms11020255
Submission received: 27 December 2022 / Revised: 12 January 2023 / Accepted: 17 January 2023 / Published: 19 January 2023
(This article belongs to the Special Issue Diversity of Mycobacterium tuberculosis)
Browse Figures
Versions Notes

Abstract

:
The Beijing genotype is the main family of Mycobacterium tuberculosis in Russia. We analyzed its diversity and drug resistance in provinces across Northwestern Russia to identify the epidemiologically relevant Beijing strains. The study collection included 497 isolates from newly-diagnosed tuberculosis (TB) patients. Bacterial isolates were subjected to drug-susceptibility testing and genotyping. The Beijing genotype was detected in 57.5% (286/497); 50% of the Beijing strains were multidrug-resistant (MDR). Central Asian/Russian and B0/W148 groups included 176 and 77 isolates, respectively. MDR was more frequent among B0/W148 strains compared to Central Asian/Russian strains (85.7% vs. 40.3%, p < 0.0001). Typing of 24 minisatellite loci of Beijing strains revealed 82 profiles; 230 isolates were in 23 clusters. The largest Central Asian/Russian types were 94-32 (n = 75), 1065-32 (n = 17), and 95-32 (n = 12). B0/W148 types were 100-32 (n = 59) and 4737-32 (n = 5). MDR was more frequent in types 1065-32 (88.2%), 100-32 (83.1%), and 4737-32 (100%). In contrast, type 9391-32 (n = 9) included only drug-susceptible strains. To conclude, M. tuberculosis Beijing genotype is dominant in Northwestern Russia, and an active transmission of overwhelmingly MDR B0/W148 types explains the reported increase of MDR-TB. The presence of MDR-associated minor variants (type 1071-32/ancient Beijing and Central Asia Outbreak strain) in some of the studied provinces also requires attention.

1. Introduction

Mycobacterium tuberculosis has a clonal population structure that includes nine phylogenetic lineages, of which Lineage 2 (or East-Asian lineage) is one of the most widespread. The Beijing genotype (L2.2) is a main component of Lineage 2. It is presently found on all continents but is most common in Asia and Europe [1,2,3]. At the same time, in countries with a high burden of tuberculosis (TB), Beijing strains are associated with drug resistance, including primary multidrug resistance (MDR), i.e., resistance to at least rifampin and isoniazid [3]. A higher adaptive capacity and resistance to anti-TB drugs in Beijing strains compared to other genotypes were attributed in some studies to a high mutation rate in vitro and in vivo although this issue remains controversial [4,5,6]. The Beijing genotype is divided into phylogenetic sublineages (ancient/ancestral and modern), based on variation associated with some genome regions, such as IS1547, Rv3135, RD181, NTF, and SNPs in mutT2 and mutT4 [7,8,9,10,11,12].
The M. tuberculosis Beijing genotype is associated with insufficient treatment efficacy and recurrence of the disease due to an increased ability of these strains to acquire drug resistance, although this is variable across Beijing subtypes and countries [13,14,15,16]. Similarly, different Beijing strains vary in their virulence properties. Beijing strains have an increased ability to inhibit protective immunity in the lungs by inducing higher levels of type I interferons, which lead to a decrease in the level of some pro-inflammatory cytokines, reducing T-cell activation [13]. However, single Beijing isolates do not represent all the diversity of the Beijing genotype, and even within the same group of related isolates a diversity of their virulence was shown in murine model studies [16,17].
The differentiation of sublineages and clusters of the Beijing genotype is not only a matter of classification but is of clinical and epidemiological significance. In Vietnam, resistance to isoniazid and streptomycin was more often observed in Beijing strains of the ancient sublineage [14]. In Russia, two MDR/pre-extensively drug-resistant (pre-XDR) clusters of ancient Beijing sublineage have recently been identified in Siberia and Russia Far-East within RD181-intact (Multi-locus VNTR analysis [MLVA] type 14717-15) and RD181-deleted (type 1071-32) groups [15]; the former was hypervirulent and highly lethal in a murine model [16]. Among predominant modern strains of the Beijing genotype in Russia, two large clusters are the most known: the notorious epidemic strain B0/W148 (~CC2 clonal complex [2], type 100-32) and Central Asian/Russian clade (~CC1 [2], type 94-32). Their 24 mycobacterial interspersed repetitive units-variable number of tandem repeats (MIRU-VNTR) profiles differ in MIRU26 and QUB26 loci (7 and 7 repeats for type 100-32; 5 and 8 repeats for type 94-32). An important strain within the Central Asian/Russian clade is the so-called Central Asia Outbreak (CAO) strain, which is MDR and endemically prevalent in Central Asia, but as of yet appears infrequently in European Russia [18]. Whereas the epidemiological and clinical significance of the B0/W148 cluster in Russia was demonstrated by numerous studies, the role of the more common and heterogeneous Central Asian/Russian clade and its CAO subtype remains to be assessed.
Here, we performed the molecular characterization of M. tuberculosis isolates of the Beijing genotype and its major endemic and epidemic subtypes in different regions across Northwestern Russia. We analyzed isolates recovered from newly diagnosed patients to understand what strains are actively transmitted and therefore impact the current situation of MDR-TB in Russia and, potentially, in neighboring countries and countries that receive Russian migrants and tourists.

2. Materials and Methods

2.1. Study Setting and Bacterial Strains

The survey area included six provinces of Northwestern Russia (https://en.wikipedia.org/wiki/Northwestern_Federal_District, accessed on 10 January 2023). Most of the studied regions have a border with the European Union. The Republic of Karelia has a long border with Finland. The Kaliningrad region in the westernmost area of Russia (semi-exclave) borders Poland and Lithuania. Most of the Murmansk region is located north of the Arctic Circle on the Kola Peninsula and has a common border with Finland and Norway. Finally, the Pskov region borders the EU (Estonia and Latvia), as well as Belarus.
The main criteria for inclusion of M. tuberculosis isolates/TB patients in the study were: (i) newly diagnosed patients with pulmonary TB; (ii) culture isolation between January 2014 and December 2018 (for most regions it was a one-year period); (iii) first available M. tuberculosis culture isolated prior to treatment; (iv) patient age ≥ 18 years old; (v) availability of accompanying information (gender, age, diagnosis).
A total of 497 strains of M. tuberculosis were studied from six regions of Northwestern Russia: Karelia (n = 67, 2014–2015), Kaliningrad (n = 73, 2015), Murmansk (n = 67, 2017), Komi (n = 130, 2017), Pskov (n = 78, 2018), and Vologda (n = 82, 2018). These isolates included all available samples within the survey period and corresponded to the above criteria of sampling.

2.2. Drug Susceptibility Testing

M. tuberculosis drug susceptibility testing for first- and second-line drugs was performed using a modified proportion method on Middlebrook 7H9 liquid culture and Bactec MGIT 960 system (Becton Dickinson, Sparks, MD, USA) according to the manufacturer’s instructions. The critical drug concentrations used were 1.0 μg/mL for streptomycin, 0.1 μg/mL for isoniazid, 5.0 μg/mL for ethambutol, 1.0 μg/mL for rifampicin, 100 μg/mL for pyrazinamide, 1.0 μg/mL for amikacin, 2.5 μg/mL for capreomycin, 2.0 μg/mL for ofloxacin, and 5 μg/mL for ethionamide.

2.3. Genotyping

M. tuberculosis DNA was extracted as described previously according to the standard protocol [19]. Initially, the strains were differentiated into Beijing and non-Beijing strains based on PCR detection of the Beijing genotype-specific IS6110 insertion in dnaA-dnaN regions as described [20]. The main Russian Beijing subtypes (B0/W148-cluster, Central Asian/Russian cluster, and CAO strain) were detected by PCR-RFLP or real-time PCR analysis of the specific genome regions as described previously [18,21,22,23].
Beijing sublineages (ancient, early ancient, modern) were detected by PCR/gel-electrophoresis analysis of the RD181 deletion and NTF locus (presence/absence of IS6110) as described [10,12,24].
Typing of 24 minisatellite MIRU-VNTR loci was performed according to Supply et al. [25]. The obtained profiles were assigned MLVA codes through comparison with MIRU-VNTRplus.org online tool. In addition, the profiles were assigned to the clonal complexes (CC) within the Beijing genotype through comparison with the large dataset of the Beijing genotype [2]. Of note, some of the VNTR-based CCs described in the study of Merker et al. [2] are polyphyletic and unsupported by robust whole-genome sequencing (WGS) data, e.g., CC3 and CC4.
Hunter Gaston Index (HGI) was calculated at http://insilico.ehu.es/mini_tools/discriminatory_power/index.php (accessed on 10 December 2022). The Shannon index was calculated at https://www.easycalculation.com/statistics/shannon-wiener-diversity.php (accessed on 10 December 2022). The two indices were calculated since more widely used HGI places more weight on species evenness than it does on richness. On the other hand, the Shannon index quantifies the uncertainty in predicting the species identity of an individual that is taken at random from the dataset and accounts for both the abundance and evenness of the species present [26].
The level of clustering (clustering rate) of strains was estimated by the formula: CR = (nc − c)/n, where nc is the total number of clustered strains, c is the number of clusters, and n is the total number of strains [27]. In this study, a MIRU-VNTR cluster was considered a group consisting of two or more strains identical in 24 loci. The clustering rate served to assess the diversity of the total and regional collections based on all tested VNTR loci.

3. Results

3.1. Main Genotype Clusters

The 497 M. tuberculosis isolates were recovered from 497 pulmonary TB patients. The main diagnoses were infiltrative (66.2%) and disseminated (18.8%) TB followed by fibrous-cavernous, focal, and other TB forms (caseous pneumonia, etc.) together were diagnosed in 15%. Three hundred and fifty-three patients were male (71%, 18 to 88 years old, mean age 43.7 years), and 144 were female (29%, 18 to 86 years, mean age 43.0 years).
The Beijing genotype was identified in 286 (57.5%) of 497 M. tuberculosis strains. Eight isolates were assigned to the ancient Beijing sublineage (intact NTF) while other Beijing isolates belonged to the modern Beijing sublineage (NTF::IS6110 allele). In the Beijing structure, the most numerous genetic groups were Central Asian/Russian, including the CAO subtype (61.5%; 176/286 strains) and B0/W148 (26.9%; 77/286). The proportion of the CAO subtype of the Central Asian/Russian clade was 10.8% (19/176), or 6.6% of all Beijing isolates. The six regions differed significantly (p < 0.001) in the number of M. tuberculosis strains of the Central Asian/Russian and B0/W148 groups (Table 1).
The largest proportion of the Central Asian/Russian clade (66.7%), as well as the smallest proportion of the B0/W148 cluster (11.8%), were found in the Beijing collection of Vologda. In Karelia, Komi, and Kaliningrad, the proportions of B0/W148 cluster strains exceeded one-third of the entire Beijing population.

3.2. High-Resolution Population Structure

The heterogeneity of the studied Beijing subtypes was assessed by 24-loci MIRU-VNTR typing. Table 2 presents HGI values for each of the 24 MIRU-VNTR loci of Beijing Central Asian/Russian and B0/W148 subtypes. In Central Asian/Russian strains (n = 176), the QUB26 (HGI 0.382) and ETRA (HGI 0.224) loci were the most variable; 9 (37.5%) of 24 loci were homogeneous (HGI 0). Strains of B0/W148 (n = 77) represented a more homogeneous group compared to Central Asian/Russian strains, since they did not differ in 15 (62.5%) of the 24 MIRU-VNTR loci. MIRU31 was the most polymorphic locus in B0/W148 strains (HGI 0.123), although its value was very low.
The 24-MIRU-VNTR diversity assessed with HGI was 0.713 for all Beijing strains. For particular genotypes, it differed significantly, and was 0.83 for the Central Asian/Russian group (with and without CAO strains), compared to the very low diversity of the CAO group (0.47) and B0/W148 (0.41).
24-MIRU-VNTR typing of 286 Beijing strains revealed 82 variants of digital profiles (Supporting Table S1). Of these, 24 profiles were represented by clusters, including from 2 to 75 strains, which amounted to 80.4% (230/286) of strains. The remaining strains each had individual profiles. The minimum spanning tree of the VNTR profiles is shown in Figure 1.
Twenty-five isolates of the modern Beijing sublineage did not belong to Central Asian/Russian or to B0/W148 groups and were grouped into 4 clusters: 9391-32 (9 strains), while 9380-32, 1066-32, and 1048-32 included 2 strains each and 10 individual profiles.
Six isolates of the ancient Beijing sublineage were assigned to type 1071-32, and two other ancient Beijing isolates had unique 24-MIRU-VNTR profiles. Previously, it was shown that 1071-32 strains belong to the early ancient sublineage of the Beijing genotype characterized by mutT2-58 and mutT4-48 wild-type alleles and deleted RD181 region [15].
Among 82 MIRU-VNTR24 profiles of 288 Beijing strains, 59 types were identified according to the MIRU-VNTRplus nomenclature. The 24-MIRU-VNTR profiles of Central Asian/Russian and B0/W148 subtypes are shown in Table 3.
Most of the B0/W148 strains (68 out of 77) belonged to four MIRU-VNTR clusters, the largest being 100-32 (59 isolates). A total of 52 MIRU-VNTR profiles were identified in 176 Beijing Central Asian/Russian strains: 37 isolates had individual profiles and 139 were in 15 clusters. Of these, the three largest types (n > 10) were 94-32 (n = 75), 1065-32 (n = 17), and 95-32 (n = 12) (Table 3). The majority (15 of 19) of CAO isolates had a 94-32 profile, which is a basal profile of the Central Asian/Russian clade. The other 4 isolates were single locus variants of type 94-32. In this view, 24-loci typing was not suitable to distinguish CAO isolates from other Central Asian/Russian isolates.
The largest MIRU-VNTR clusters of M. tuberculosis Beijing genotype were analyzed in the regional subpopulations (Figure 2; Table 4). The B0/W148 type 100-32 accounted for 25–28% of strains in Kaliningrad, Komi and Karelia compared to only 7.8% of strains in Vologda. In Komi, B0/W148 type 4737-32 (4.1%) was also identified in a minor proportion. Central Asian/Russian type 94-32 predominated in Murmansk (42.9%) and Vologda (35.3%) as opposed to making up 13.0% in Kaliningrad. Central Asian/Russian strains were also represented by cluster 1065-32 in Komi, Pskov, and Vologda (where cluster 95-32-16% was also found). CAO isolates were found in relatively high proportion in Vologda (13.7% of all Beijing), Kaliningrad (8.7%), and Karelia (8.4%) compared to only making up only 2–4% of isolates in Komi, Murmansk, and Pskov. Regarding Beijing isolates beyond B0/W148 and Central Asian/Russian, type 9391-32 of the modern Beijing sublineage was present in Murmansk, Kaliningrad, Pskov, and Karelia. Strains of type 1071-32 of the ancient Beijing sublineage were found in 8.3% of the Beijing population in Karelia and were very low prevalent or absent in other regions.
The VNTR diversity of regional populations is also summarized in Table 4 in terms of the number of different profiles and clusters and assessed using Hunter Gaston and Shannon indices. Both indices (reflecting type richness and evenness), as well as the CR index, concordantly indicated the lowest diversity of the Murmansk collection and the highest for Pskov and Kaliningrad.

3.3. Drug Resistance versus Genotypes

The Beijing subtypes differed in phenotypic drug susceptibility (Table 2). The vast majority of drug-susceptible Beijing strains were represented by strains of the Central Asian/Russian cluster (97.1%), while no susceptible B0/W148 strains were found. The Central-Asian/Russian CAO subtype strains were all drug-resistant, and 57.9% were MDR (Table 5).
The largest MIRU types differed significantly in their drug resistance (Table 6). The largest proportion of MDR isolates was detected in types 100-32 and 4737-32 (both within B0/W148), 1065-32 (Central Asian/Russian), and 1071-32 (ancient sublineage). Central Asian/Russian strains included MIRU types heterogeneous in drug resistance. The largest type 94-32 included drug-susceptible and MDR strains in equal proportions (44.0% each). However, a closer look revealed that the 94-32 CAO subgroup included only drug-resistant (mostly MDR) isolates.
All isolates of type 9391-32 (modern sublineage but not Central Asian/Russian or B0/W148) were drug-susceptible. On the contrary, all six isolates of type 1071-32 (ancient sublineage) were MDR.

4. Discussion

The situation with TB in Russia is characterized by decreasing incidence (from 85.1/100,000 in 2008 to 41.2/100,000 in 2019), but increasing circulation of drug-resistant strains. The MDR-TB rate among newly-diagnosed patients in Russia increased from 13.0% in 2009 to 29.0% in 2018 [https://last.mednet.ru/images/materials/CMT/tuberkulez-2019.pdf, accessed on 1 December 2022]. Northwestern Russia has a somewhat better situation with TB compared to Siberia and Far East Russia (where TB/HIV coinfection presents a serious adverse factor). In Northwestern Russia, TB incidence decreased from 57.5/100,000 in 2010 to 25.2/100,000 in 2019 [28,29]. However, the primary MDR rate here is also high and knowledge of the high-resolution population structure is needed to timely identify the most hazardous M. tuberculosis variants, monitor their spread, and implement adequate TB control measures.
This study demonstrated that the M. tuberculosis Beijing genotype in Northwestern Russia is dominated by two large groups of the modern Beijing sublineage, Central Asian/Russian (61.5%) and B0/W148 (26.9%). Within the Central Asian/Russian clade, a Central Asia-successful CAO strain was detected at a minor prevalence rate (6.6% of all Beijing strains). The 24-MIRU-VNTR diversity of the B0/W148 and CAO strains was low (HGI = 0.41 and 0.46) suggesting their relatively more recent origin and more recent spread compared to Central Asian/Russian clade (HGI = 0.83).
All Beijing variants identified herein (except for CAO) are endemic Russian strains [7,12,18,21,22,23,30,31,32,33,34,35,36]. In this study, the vast majority of B0/W148 strains (88.3%) were assigned to four clusters of the CC2 clonal complex: 100-32 (86.8%), 4737-32, 1075-32, and 9378-32. Type 100-32 strains can be found in the former Soviet Union, Europe, and the USA (brought with FSU immigrants) [37,38,39,40,41], and in negligibly small prevalence rates in China, Korea, and Vietnam [2]. Russian B0/W148 strain likely originated in Siberia within the ancestral 100-32 subpopulation in the 1950s and further spread towards the European part of Russia in the 1960-1980s, followed by even wider dissemination by Russian immigrants in Europe and North America [37]. This conclusion was confirmed by a more recent WGS study [42].
The location of origin of the Russian Central Asian/Russian clade is presently unknown. The majority of these strains (79.0%) were assigned to 15 MIRU-VNTR types. Types 95-32 (6.8%; 12), 1065-32 (9.7%; 17), and the largest 94-32 (42.6%; 75) are widely distributed across the Russian Federation and post-Soviet countries, particularly dominating in Kazakhstan [34,35,36,39,40,41] although in the latter case, the contribution of the CAO strain is not known. For example, in Uzbekistan, the Central Asian/Russian clade is almost exclusively represented by the CAO strains [43]. The CAO strain is rarely found in Russia, e.g., 7% in Samara, Central Russia [44] and 6.4% in Omsk, Western Siberia [45]. Its presence in Omsk is not surprising since this Russian region borders northern Kazakhstan.
Regarding other minor variants, a drug-susceptible type 9391-32 (3% in this study) falls within type M41 in the 12-MIRU-VNTR database of Mokrousov et al. [46]. In that database, M41 is a minor variant that was detected >10 years ago in single isolates in the earlier studies in Northwestern Russia (Pskov, Kaliningrad, St. Petersburg) and was also described in Lithuania (4 drug-susceptible out of 157 Beijing isolates [2]). Finally, MDR/pre-XDR type 1071-32 belongs to the early ancient Beijing sublineage, recently discovered in Western Siberia at 10% and endemic to Russia; its secondary single isolates were described in parts of the Former Soviet Union and Eastern Europe [47].
The Central Asian/Russian clade (including CAO) had a significantly lower MDR rate (40.3%) than B0/W148 (85.7%). Comparative analysis of the phenotypic drug resistance of Beijing strains of the main MIRU-VNTR clusters showed a dominance of MDR strains in clusters 1071-32 (ancient sublineage, 100%), 4737-32 (B0/W148, 100%), 1065-32 (Central Asian/Russian, 88.2%) and 100-32 (B0/W148 (83.1%). Previously, MDR 4737-32 isolates were detected in Armenia, Lithuania, and some Western European countries, in particular, Portugal, with suggested FSU origin [2,48,49]. MDR type 1065-32 isolates were identified in Europe, with the largest proportion in Lithuania (32.7%; 17/52 Beijing strains) [2] and Estonia (31.0%; 9/29 Beijing strains) [50]. In our study, the largest proportions of MDR 1065-32 strains were found in the Pskov region bordering Estonia (35.3%; 6/17) but also in the inland Komi region (17.5%; 7/40). This reconfirms the Russian origin of this type that is geographically widespread in Russia (while time and location are unknown), and its subsequent penetration to Latvia and Estonia through human exchange with Russia.
While most of the studied provinces were borderline regions, the Vologda province takes a particular position (Figure 2). It is the inland Russian region and has a relatively calm epidemic situation for TB. In 2018, TB incidence here per 100,000 population was 15.8 compared to 28.6 in Northwestern Russia and 44.4 in Russia as a whole [28]. The Central Asian/Russian genotype was the most prevalent (66.7%) in Vologda where B0/W148 was at the lowest rate (11.8%). Indeed, this may account for a better situation with MDR-TB in this region. On the other hand, the higher prevalence rate of MDR-associated CAO in Vologda (13.7%) compared to other provinces of Northwestern Russia (2.9–8.7%) is noteworthy.
In this study, all CAO isolates (albeit low-prevalent, 3.8% of all M. tuberculosis collection) were drug-resistant and 58% of them were MDR. The CAO strain was shown to be MDR/pre-XDR, transmissible, and both endemic and epidemic in Central Asia [30,43], but its presence was rarely assessed in the previous Russian studies with few exceptions [18,31,43]. Unlike other Beijing variants described herein, Central Asian CAO is not an autochthonous Russian strain. Its wide dissemination in Central Asia was estimated to have started only in the 1990s after those countries gained their independence [43]. Penetration of the CAO cluster can be hypothetically attributed to the two different kinds of human migration. First, a significant migration of ethnic Russians from the former Soviet republics of Central Asia (Kazakhstan, Uzbekistan, and others) took place in the 1990s following the collapse of the Soviet Union [51,52,53]. More recently, already in the 21st century, there was a permanent and visible influx of work migrants from the same countries towards Russia. Detailed information on the volume and content of particular migration flows toward different Russian provinces is not available and any further considerations would be too speculative. Further surveillance is necessary to see if the CAO strains increase their circulation in Vologda and other targeted provinces.

5. Conclusions

The M. tuberculosis population in Northwestern Russia is dominated by the Beijing genotype (55.6%) and more than half of the Beijing strains were MDR. Two main Beijing groups B0/W148 and Central Asian/Russian differed significantly in MDR rate (85.7% vs. 40.3%, p < 0.0001). MDR-associated B0/W148 and CAO groups were dominated by single VNTR types (100-32 and 94-32) which implies the insufficient discriminatory capacity of 24-MIRU typing with regard to the epidemiologically significant Beijing types in Russia. In this view, the use of hypervariable loci may be recommended for further subtyping of these isolates. The largest VNTR types were 94-32, 1065-32, 95-32 (Central Asian/Russian), and 100-32 (B0/W148). Two-thirds of Beijing MDR strains were distributed among three MIRU-VNTR types: 100-32, 94-32, and 1065-32. The presence of MDR-associated, as yet minor genotypes (Central Asian CAO strain and Siberian 1071-32-cluster) in some of the studied provinces also requires attention. The observed difference between the studied provinces with regard to the regional population structures may be speculatively explained by (i) differences in local implementation of the TB control programs; (ii) unknown outbreaks; or (iii) demographic or migration-related factors.
The increasing rate of primary MDR-TB in Northwestern Russia can be explained by the active transmission of the Beijing genotype strains, primarily the B0/W148 cluster associated with MDR. This poses a serious problem since the treatment of MDR-TB patients requires significant economic costs.
The results of this study lay a foundation for epidemiological monitoring of the circulating M. tuberculosis strains and molecular epidemiology of tuberculosis in Northwestern Russia. Molecular epidemiology and permanent surveillance of the circulation of the epidemic, potentially emerging genotypes, or imported strains should become an integral part of the national TB control program.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/microorganisms11020255/s1, Table S1: Information on all studied isolates of Mycobacterium tuberculosis Beijing genotype: origin, drug resistance, and 24-MIRU-VNTR loci profile.

Author Contributions

Conceptualization: A.V.; Investigation: A.V., A.G., R.M., D.T. and N.S.; Formal analysis: A.V. and I.M.; Writing, original draft: A.V.; Writing—Review & Editing: I.M. and V.Z.; Supervision: A.V., I.M. and V.Z.; Funding acquisition: I.M. All authors have read and agreed to the published version of the manuscript.

Funding

This study was supported by Russian Science Foundation (grant 19-14-00013).

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki, and approved by the Ethics Committees of the St. Petersburg Research Institute of Phthisiopulmonology (Protocol 31.2 of 27 February 2017) and St. Petersburg Pasteur Institute (Protocol 61 of 2 April 2020).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

All data of this study are presented in this article and Supplementary material.

Acknowledgments

We gratefully thank colleagues (R.A. Tarashkevich, S.A. Bogatin, G.M. Akhmedova, E.N. Turkin, N.Y. Gavrilova, A.O. Bychkova, E.V. Anikieva, T.V. Sunchalina, E.E. Proshina, S.V. Toinova, I.A. Lebedeva, N.B. Ushakova, and V.V. Pavlov) from regional tuberculosis dispensaries for providing bacterial isolates. We thank Olga Narvskaya for valuable advice on different aspects of this project.

Conflicts of Interest

Authors declare no conflict of interest.

References

  1. van Soolingen, D.; Qian, L.; de Haas, P.E.W.; Douglas, J.T.; Traore, H.; Portaels, F.; Qing, H.Z.; Enkhsaikan, D.; Nymadawa, P.; van Embden, J.D. Predominance of a single genotype of Mycobacterium tuberculosis in countries of East Asia. J. Clin. Microbiol. 1995, 33, 3234–3238. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Merker, M.; Blin, C.; Mona, S.; Duforet-Frebourg, N.; Lecher, S.; Willery, E.; Blum, M.G.; Rüsch-Gerdes, S.; Mokrousov, I.; Aleksic, E.; et al. Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage. Nat. Genet. 2015, 47, 242–249. [Google Scholar] [CrossRef] [PubMed]
  3. Glynn, J.R.; Whiteley, J.; Bifani, P.J.; Kremer, K.; van Soolingen, D. Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: A systematic review. Emerg. Infect. Dis. 2002, 8, 843–849. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Ford, C.B.; Shah, R.R.; Maeda, M.K.; Gagneux, S.; Murray, M.B.; Cohen, T.; Johnston, J.C.; Gardy, J.; Lipsitch, M.; Fortune, S.M. Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug-resistant tuberculosis. Nat. Genet. 2013, 45, 784–790. [Google Scholar] [CrossRef] [Green Version]
  5. Hakamata, M.; Takihara, H.; Iwamoto, T.; Tamaru, A.; Hashimoto, A.; Tanaka, T.; Kaboso, S.A.; Gebretsadik, G.; Ilinov, A.; Yokoyama, A.; et al. Higher genome mutation rates of Beijing lineage of Mycobacterium tuberculosis during human infection. Sci. Rep. 2020, 10, 17997. [Google Scholar] [CrossRef]
  6. Werngren, J.; Hoffner, S.E. Drug-susceptible Mycobacterium tuberculosis Beijing genotype does not develop mutation-conferred resistance to rifampin at an elevated rate. J. Clin. Microbiol. 2003, 41, 1520–1524. [Google Scholar] [CrossRef] [Green Version]
  7. Mokrousov, I.; Narvskaya, O.; Otten, T.; Vyazovaya, A.; Limeschenko, E.; Steklova, L.; Vyshnevskyi, B. Phylogenetic reconstruction within Mycobacterium tuberculosis Beijing genotype in northwestern Russia. Res. Microbiol. 2002, 153, 629–637. [Google Scholar] [CrossRef]
  8. Ebrahimi-Rad, M.; Bifani, P.; Martin, C.; Kremer, K.; Samper, S.; Rauzier, J.; Kreiswirth, B.; Blazquez, J.; Jouan, M.; van Soolingen, D.; et al. Mutations in putative mutator genes of Mycobacterium tuberculosis strains of the W-Beijing family. Emerg. Infect. Dis. 2003, 9, 838–845. [Google Scholar] [CrossRef] [Green Version]
  9. Tsolaki, A.G.; Hirsh, A.E.; De Riemer, K.; Enciso, J.A.; Wong, M.Z.; Hannan, M.; de la Salmoniere, Y.O.L.G.; Aman, K.; Kato-Maeda, M.; Small, P.M. Functional and evolutionary genomics of Mycobacterium tuberculosis: Insights from genomic deletions in 100 strains. Proc. Natl. Acad. Sci. USA 2004, 101, 4865–4870. [Google Scholar] [CrossRef] [Green Version]
  10. Mokrousov, I.; Ly, H.M.; Otten, T.; Lan, N.N.; Vyshnevskyi, B.; Hoffner, S.; Narvskaya, O. Origin and primary dispersal of the Mycobacterium tuberculosis Beijing genotype: Clues from human phylogeography. Genome Res. 2005, 15, 1357–1364. [Google Scholar] [CrossRef]
  11. Tsolaki, A.G.; Gagneux, S.; Pym, A.S.; Goguet de la Salmoniere, Y.O.; Kreiswirth, B.N.; van Soolingen, D.; Small, P.M. Genomic deletions classify the Beijing/W strains as a distinct genetic lineage of Mycobacterium tuberculosis. J. Clin. Microbiol. 2005, 43, 3185–3191. [Google Scholar] [CrossRef] [Green Version]
  12. Yin, Q.Q.; Liu, H.C.; Jiao, W.W.; Li, Q.J.; Han, R.; Tian, J.L.; Liu, Z.G.; Zhao, X.Q.; Li, Y.J.; Wan, K.L.; et al. Evolutionary History and Ongoing Transmission of Phylogenetic Sublineages of Mycobacterium tuberculosis Beijing Genotype in China. Sci. Rep. 2016, 6, 34353. [Google Scholar] [CrossRef]
  13. Mourik, B.C.; de Steenwinkel, J.E.M.; de Knegt, G.J.; Huizinga, R.; Verbon, A.; Ottenhoff, T.H.M.; van Soolingen, D.; Leenen, P.J.M. Mycobacterium tuberculosis clinical isolates of the Beijing and East-African Indian lineage induce fundamentally different host responses in mice compared to H37Rv. Sci. Rep. 2019, 9, 19922. [Google Scholar] [CrossRef] [Green Version]
  14. Maeda, S.; Hang, N.T.; Lien, L.T.; Thuong, P.H.; Hung, N.V.; Hoang, N.P.; Cuong, V.C.; Hijikata, M.; Sakurada, S.; Keicho, N. Mycobacterium tuberculosis strains spreading in Hanoi, Vietnam: Beijing sublineages, genotypes, drug susceptibility patterns, and host factors. Tuberculosis 2014, 94, 649–656. [Google Scholar] [CrossRef] [Green Version]
  15. Mokrousov, I.; Vyazovaya, A.; Pasechnik, O.; Gerasimova, A.; Dymova, M.; Chernyaeva, E.; Tatarintseva, M.; Stasenko, V. Early ancient sublineages of Mycobacterium tuberculosis Beijing genotype: Unexpected clues from phylogenomics of the pathogen and human history. Clin. Microbiol. Infect. 2019, 25, 1039.e1–1039.e6. [Google Scholar] [CrossRef]
  16. Vinogradova, T.; Dogonadze, M.; Zabolotnykh, N.; Badleeva, M.; Yarusova, I.; Vyazovaya, A.; Gerasimova, A.; Zhdanova, S.; Vitovskaya, M.; Solovieva, N.; et al. Extremely lethal and hypervirulent Mycobacterium tuberculosis strain cluster emerging in Far East, Russia. Emerg. Microbes Infect. 2021, 10, 1691–1701. [Google Scholar] [CrossRef]
  17. Bespyatykh, J.A.; Vinogradova, T.I.; Manicheva, O.A.; Zabolotnykh, N.V.; Dogonadze, M.Z.; Vitovskaya, M.L.; Guliaev, A.S.; Zhuravlev, V.Y.; Shitikov, E.A.; Ilina, E.N. In vivo virulence of Beijing genotype Mycobacterium tuberculosis. Russ. J. Infect. Immun. 2019, 9, 173–182. (In Russian) [Google Scholar] [CrossRef] [Green Version]
  18. Shitikov, E.; Vyazovaya, A.; Malakhova, M.; Guliaev, A.; Bespyatykh, J.; Proshina, E.; Pasechnik, O.; Mokrousov, I. Simple Assay for detection of the Central Asia outbreak clade of the Mycobacterium tuberculosis Beijing genotype. J. Clin. Microbiol. 2019, 57, e00215-19. [Google Scholar] [CrossRef] [Green Version]
  19. van Embden, J.D.; Cave, M.D.; Crawford, J.T.; Dale, J.W.; Eisenach, K.D.; Gicquel, B.; Hermans, P.; Martin, C.; McAdam, R.; Shinnick, T.M.; et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: Recommendations for a standardized methodology. J. Clin. Microbiol. 1993, 31, 406–409. [Google Scholar] [CrossRef] [Green Version]
  20. Mokrousov, I.; Vyazovaya, A.; Zhuravlev, V.; Otten, T.; Millet, J.; Jiao, W.W.; Shen, A.D.; Rastogi, N.; Vishnevsky, B.; Narvskaya, O. Real-time PCR assay for rapid detection of epidemiologically and clinically significant Mycobacterium tuberculosis Beijing genotype isolates. J. Clin. Microbiol. 2014, 52, 1691–1693. [Google Scholar] [CrossRef]
  21. Mokrousov, I.; Narvskaya, O.; Vyazovaya, A.; Otten, T.; Jiao, W.W.; Gomes, L.L.; Suffys, P.N.; Shen, A.D.; Vishnevsky, B. Russian “successful” clone B0/W148 of Mycobacterium tuberculosis Beijing genotype: A multiplex PCR assay for rapid detection and global screening. J. Clin. Microbiol. 2012, 50, 3757–3759. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  22. Mokrousov, I.; Chernyaeva, E.; Vyazovaya, A.; Skiba, Y.; Solovieva, N.; Valcheva, V.; Levina, K.; Malakhova, N.; Jiao, W.W.; Gomes, L.L.; et al. Rapid assay for detection of the epidemiologically important Central Asian/Russian strain of the Mycobacterium tuberculosis Beijing genotype. J. Clin. Microbiol. 2018, 56, e01551-17. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Shitikov, E.; Kolchenko, S.; Mokrousov, I.; Bespyatykh, J.; Ischenko, D.; Ilina, E.; Govorun, V. Evolutionary pathway analysis and unified classification of East Asian lineage of Mycobacterium tuberculosis. Sci. Rep. 2017, 7, 9227. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Iwamoto, T.; Grandjean, L.; Arikawa, K.; Nakanishi, N.; Caviedes, L.; Coronel, J.; Sheen, P.; Wada, T.; Taype, C.A.; Shaw, M.A.; et al. Genetic diversity and transmission characteristics of Beijing family strains of Mycobacterium tuberculosis in Peru. PLoS ONE 2012, 7, e49651. [Google Scholar] [CrossRef] [PubMed]
  25. Supply, P.; Allix, C.; Lesjean, S.; Cardoso-Oelemann, M.; Rüsch-Gerdes, S.; Willery, E.; Savine, E.; de Haas, P.; van Deutekom, H.; Roring, S.; et al. Proposal for standardization of optimized Mycobacterial interspersed repetitive Unit-Variable-Number Tandem Repeat Typing of Mycobacterium tuberculosis. J. Clin. Microbiol. 2006, 44, 4498–4510. [Google Scholar] [CrossRef] [Green Version]
  26. Mokrousov, I. Revisiting the Hunter Gaston discriminatory index: Note of caution and courses of change. Tuberculosis. 2017, 104, 20–23. [Google Scholar] [CrossRef]
  27. Supply, P.; Lesjean, S.; Savine, E.; Kremer, K.; van Soolingen, D.; Locht, C. Automated high-throughput genotyping for study of global epidemiology of Mycobacterium tuberculosis based on mycobacterial interspersed repetitive units. J. Clin. Microbiol. 2001, 39, 3563–3571. [Google Scholar] [CrossRef] [Green Version]
  28. Nechaeva, O.B.; Gordina, A.V.; Sterlikov, S.A.; Kucheryavaya, D.A.; Dergachev, A.V.; Ponomarev, S.B.; Burykhin, V.S. Resources and Activities of TB Organizations in the Russian Federation in 2018–2019 (Statistical Materials); RIO TsNIIOIZ: Moscow, Russia, 2020; 99p. [Google Scholar]
  29. Galkin, V.B.; Sterlikov, S.A.; Yablonsky, P.K.; Beltyukov, M.V.; Grishko, A.N.; Baglina, S.S.; Vasilyeva, T.V.; Danilova, T.I.; Kononenko, Y.S.; Kulizhskaya, A.I.; et al. Dynamics of the Prevalence of Multidrug-Resistant Tuberculosis and HIV Infection in the North-West Region of Russia. Meditsinskiy Alians 2019, 6–23. (In Russian) [Google Scholar]
  30. Mokrousov, I.; Valcheva, V.; Sovhozova, N.; Aldashev, A.; Rastogi, N.; Isakova, J. Penitentiary population of Mycobacterium tuberculosis in Kyrgyzstan: Exceptionally high prevalence of the Beijing genotype and its Russia-specific subtype. Infect. Genet. Evol. 2009, 9, 1400–1405. [Google Scholar] [CrossRef]
  31. Vyazovaya, A.A.; Pasechnik, O.A.; Gerasimova, A.A.; Mokrousov, I.V. Population structure of the Beijing Mycobacterium tuberculosis genetic family in Western Siberia. Tuberc. Lung Dis. 2020, 98, 32–36. (In Russian) [Google Scholar] [CrossRef]
  32. Dymova, M.A.; Kinsht, V.N.; Cherednichenko, A.G.; Khrapov, E.A.; Svistelnik, A.V.; Filipenko, M.L. Highest prevalence of the Mycobacterium tuberculosis Beijing genotype isolates in patients newly diagnosed with tuberculosis in the Novosibirsk oblast, Russian Federation. J. Med. Microbiol. 2011, 60 Pt 7, 1003–1009. [Google Scholar] [CrossRef]
  33. Afanas’ev, M.V.; Ikryannikova, L.N.; Il’ina, E.N.; Kuz’min, A.V.; Larionova, E.E.; Smirnova, T.G.; Chernousova, L.N.; Govorun, V.M. Molecular typing of Mycobacterium tuberculosis circulated in Moscow, Russian Federation. Eur. J. Clin. Microbiol. Infect. Dis. 2011, 30, 181–191. [Google Scholar] [CrossRef]
  34. Zhdanova, S.; Mokrousov, I.; Orlova, E.; Sinkov, V.; Ogarkov, O. Transborder molecular analysis of drug-resistant tuberculosis in Mongolia and Eastern Siberia, Russia. Transbound. Emerg. Dis. 2022, 69, e1800–e1814. [Google Scholar] [CrossRef]
  35. Zhdanova, S.N.; Ogarkov, O.B.; Alekseeva, G.I.; Vinokurova, M.K.; Sinkov, V.V.; Savilov, E.D.; Kravchenko, A.F. Genetic diversity of Mycobacterium tuberculosis isolates from Sakha (Yakutia), Russia. Mol. Genet. Microbiol. Virol. 2016, 31, 51–57. [Google Scholar] [CrossRef]
  36. Khromova, P.A.; Kornilov, M.S.; Zhdanova, S.N.; Yakovleva, A.A.; Ogarkov, O.B. Identification of epidemic subtypes of the Beijing Mycobacterium tuberculosis genotype circulating in Primorsky Krai. Acta Biomed. Sci. 2018, 3, 154–158. (In Russian) [Google Scholar]
  37. Mokrousov, I. Insights into the origin, emergence, and current spread of a successful Russian clone of Mycobacterium tuberculosis. Clin. Microbiol. Rev. 2013, 26, 342–360. [Google Scholar] [CrossRef] [Green Version]
  38. De Beer, J.L.; Kodmon, C.; van der Werf, M.J.; van Ingen, J.; van Soolingen, D. ECDC MDR-TB Molecular Surveillance Project Participants. Molecular surveillance of multi- and extensively drug-resistant tuberculosis transmission in the European Union from 2003 to 2011. Euro Surveill 2014, 19, 20742. [Google Scholar] [CrossRef] [Green Version]
  39. Pole, I.; Trofimova, J.; Norvaisa, I.; Supply, P.; Skenders, G.; Nodieva, A.; Ozere, I.; Riekstina, V.; Igumnova, V.; Storozenko, J.; et al. Analysis of Mycobacterium tuberculosis genetic lineages circulating in Riga and Riga region, Latvia, isolated between 2008 and 2012. Infect. Genet. Evol. 2020, 78, 104126. [Google Scholar] [CrossRef]
  40. Skiba, Y.; Mokrousov, I.; Ismagulova, G.; Maltseva, E.; Yurkevich, N.; Bismilda, V.; Chingissova, L.; Abildaev, T.; Aitkhozhina, N. Molecular snapshot of Mycobacterium tuberculosis population in Kazakhstan: A country-wide study. Tuberculosis 2015, 95, 538–546. [Google Scholar] [CrossRef]
  41. Mokrousov, I.; Vyazovaya, A.; Levina, K.; Gerasimova, A.; Zhuravlev, V.; Viiklepp, P.; Kütt, M. Spatiotemporal dynamics of drug-resistant Mycobacterium tuberculosis: Contrasting trends and implications for tuberculosis control in EU high-priority country. Transbound. Emerg. Dis. 2021, 68, 896–906. [Google Scholar] [CrossRef]
  42. Merker, M.; Rasigade, J.P.; Barbier, M.; Cox, H.; Feuerriegel, S.; Kohl, T.A.; Shitikov, E.; Klaos, K.; Gaudin, C.; Antoine, R.; et al. Transcontinental spread and evolution of Mycobacterium tuberculosis W148 European/Russian clade toward extensively drug resistant tuberculosis. Nat. Commun. 2022, 13, 5105. [Google Scholar] [CrossRef] [PubMed]
  43. Merker, M.; Barbier, M.; Cox, H.; Rasigade, J.P.; Feuerriegel, S.; Kohl, T.A.; Diel, R.; Borrell, S.; Gagneux, S.; Nikolayevskyy, V.; et al. Compensatory evolution drives multidrug-resistant tuberculosis in Central Asia. Elife 2018, 7, e38200. [Google Scholar] [CrossRef] [PubMed]
  44. Casali, N.; Nikolayevskyy, V.; Balabanova, Y.; Harris, S.R.; Ignatyeva, O.; Kontsevaya, I.; Corander, J.; Bryant, J.; Parkhill, J.; Nejentsev, S.; et al. Evolution and transmission of drug-resistant tuberculosis in a Russian population. Nat. Genet. 2014, 46, 279–286. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Pasechnik, O.; Vyazovaya, A.; Vitriv, S.; Tatarintseva, M.; Blokh, A.; Stasenko, V.; Mokrousov, I. Major genotype families and epidemic clones of Mycobacterium tuberculosis in Omsk region, Western Siberia, Russia, marked by a high burden of tuberculosis-HIV coinfection. Tuberculosis 2018, 108, 163–168. [Google Scholar] [CrossRef]
  46. Mokrousov, I. Mycobacterium tuberculosis phylogeography in the context of human migration and pathogen’s pathobiology: Insights from Beijing and Ural families. Tuberculosis 2015, 95 (Suppl. 1), S167–S176. [Google Scholar] [CrossRef]
  47. Mokrousov, I.; Vyazovaya, A.; Sinkov, V.; Gerasimova, A.; Ioannidis, P.; Jiao, W.; Khromova, P.; Papaventsis, D.; Pasechnik, O.; Perdigão, J.; et al. Practical approach to detection and surveillance of emerging highly resistant Mycobacterium tuberculosis Beijing 1071-32-cluster. Sci. Rep. 2021, 11, 21392. [Google Scholar] [CrossRef]
  48. European Centre for Disease Prevention and Control. Molecular Typing for Surveillance of Multidrug-Resistant Tuberculosis in the EU/EEA: Surveillance Report. Stockholm, 2017. Available online: https://www.ecdc.europa.eu/en/publications-data/molecular-typing-surveillance-multidrug-resistant-tuberculosis-eueea (accessed on 27 December 2022).
  49. Perdigão, J.; Silva, C.; Maltez, F.; Machado, D.; Miranda, A.; Couto, I.; Rabna, P.; de Sessions, P.F.; Phelan, J.; Pain, A.; et al. Emergence of multidrug-resistant Mycobacterium tuberculosis of the Beijing lineage in Portugal and Guinea-Bissau: A snapshot of moving clones by whole-genome sequencing. Emerg. Microbes Infect. 2020, 9, 1342–1353. [Google Scholar] [CrossRef]
  50. Vyazovaya, A.; Levina, K.; Zhuravlev, V.; Viiklepp, P.; Kütt, M.; Mokrousov, I. Emerging resistant clones of Mycobacterium tuberculosis in a spatiotemporal context. J. Antimicrob. Chemother. 2018, 73, 325–331. [Google Scholar] [CrossRef]
  51. In the 1990s, the Influx of Migrants to Russia from the Former Soviet Republics of the USSR Decreased. Available online: http://www.demoscope.ru/weekly/037/tema01.php (accessed on 11 January 2023). (In Russian).
  52. Migration in Post-Soviet Countries. Available online: https://russiancouncil.ru/analytics-and-comments/analytics/migratsiya-v-postsovetskikh-stranakh/ (accessed on 11 January 2023). (In Russian).
  53. In Central Asia, the Number of Ethnic Russians fell to 5.7 Million. Available online: https://www.asiaplustj.info/ru/news/tajikistan/20071120/v-tsentralnoi-azii-chislennost-etnicheskikh-russkikh-snizilas-do-57-mln (accessed on 11 January 2023). (In Russian).
Microorganisms 11 00255 g001 550
Figure 1. Minimum spanning tree of 24-MIRU-VNTR profiles of 286 strains of M. tuberculosis Beijing genotype strains. Node sizes only roughly correlate with the sample size. The number of isolates in the largest types (n > 4) is shown inside the circles in brackets. Designations of MIRU-VNTR profiles are given according to the MLVA Mtbc15-9 nomenclature. Lines between nodes show changes related to 1 locus variation (solid bold lines), 2 loci variation (solid thin lines), and >2 loci variation (dashed lines). Numbers on the lines show the number of variant alleles.
Figure 1. Minimum spanning tree of 24-MIRU-VNTR profiles of 286 strains of M. tuberculosis Beijing genotype strains. Node sizes only roughly correlate with the sample size. The number of isolates in the largest types (n > 4) is shown inside the circles in brackets. Designations of MIRU-VNTR profiles are given according to the MLVA Mtbc15-9 nomenclature. Lines between nodes show changes related to 1 locus variation (solid bold lines), 2 loci variation (solid thin lines), and >2 loci variation (dashed lines). Numbers on the lines show the number of variant alleles.
Microorganisms 11 00255 g001
Microorganisms 11 00255 g002 550
Figure 2. Geographic distribution of the Beijing VNTR types in six provinces in Northwestern Russia. HGI values are shown below the regions’ names. Free map: https://commons.wikimedia.org/wiki/File:Outline_Map_of_Northwestern_Federal_District.svg (accessed on 1 December 2022).
Figure 2. Geographic distribution of the Beijing VNTR types in six provinces in Northwestern Russia. HGI values are shown below the regions’ names. Free map: https://commons.wikimedia.org/wiki/File:Outline_Map_of_Northwestern_Federal_District.svg (accessed on 1 December 2022).
Microorganisms 11 00255 g002
Table
Table 1. M. tuberculosis Beijing genotype subgroups in the regions of Northwestern Russia.
Table 1. M. tuberculosis Beijing genotype subgroups in the regions of Northwestern Russia.
Region, Number of IsolatesNumber of Isolates (% of All Beijing)All Beijing
B0/W148Central Asian/Russian (Other Than CAO)Central Asian/Russian CAOOther Modern BeijingAncient Beijing
Vologda, n = 826 (11.8)34 (66.7)7 (13.7)3 (5.9)1 (2.0)51 (62.2)
Kaliningrad, n = 7317 (37.0)17 (37.0)4 (8.7)6 (13.0)2 (4.3)46 (63.0)
Karelia n = 6713 (36.1)15 (41.7)3 (8.3)2 (5.6)3 (8.3)36 (53.7)
Komi, n = 13026 (35.6)43 (58.9)2 (2.7)1 (1.4)1 (1.4)73 (56.2)
Murmansk, n = 677 (20.0)22 (62.9)1 (2.9)5 (14.3)035 (52.2)
Pskov, n = 788 (17.8)26 (57.8)2 (4.4)8 (17.8)1 (2.2)45 (57.7)
Table
Table 2. Allele diversity of 24 MIRU-VNTR loci in M. tuberculosis strains Beijing Central Asian/Russian and B0/W148.
Table 2. Allele diversity of 24 MIRU-VNTR loci in M. tuberculosis strains Beijing Central Asian/Russian and B0/W148.
VNTR LocusLocus AliasNumber of AllelesNumber of RepeatsHGINumber of AllelesNumber of RepeatsHGI
Central Asian/Russian (n = 176)B0/W148 (n = 77)
154MIRU02120120
424Mtub0442–50.10922.40.026
577ETRC32.4.50.067140
580MIRU04120120
802MIRU4032–40.07823–40.026
960MIRU1022.30.011130
1644MIRU16130130
1955Mtub2151.3–60.12024–50.051
2059MIRU20120120
2165ETRA41–40.224140
2347Mtub2932–40.077140
2401Mtub3022.40.03422.40.026
2461ETRB120120
2531MIRU23150150
2687MIRU24110110
2996MIRU2644–6.90.16134–6.70.077
3007MIRU27130130
3171Mtub3422.30.011130
3192MIRU3134–60.14924–50.123
3690Mtub3923–40.01132–40.052
4052QUB2655–90.38232.3.70.052
4156QUB4156120120
4348MIRU3922.30.011130
2163bQUB11b52.5–80.17025–60.076
Table
Table 3. 24-MIRU-VNTR shared types (2 isolates and more) of main genotype groups.
Table 3. 24-MIRU-VNTR shared types (2 isolates and more) of main genotype groups.
Beijing Subgroups24 Loci MIRU-VNTR ProfileMLVA MtbC 15-924-loci MITCC *Number of Isolates
Central Asian/Russian
n = 176		2233251535333246824544339358-3232CC12
223325153533424682444433801-32OrphanCC12
2233251535334226824544339357-32-CC12
2233251536334226824544339356-3271CC12
223325153533424582454433407-32-CC4 *2
223325153534424582454433770-32-CC4 *2
223325153433424682254433?-32--2
2233251435334246824544331068-32-CC3 *3
22332515353342468246443396-32-CC13
22332515353342467245243399-332-CC14
2233251635334246824544331076-32OrphanCC3 *5
22332515353342467245443399-32-CC16
22332515353332468245443395-3232CC112
2233251535334246624544331065-3228CC117
22332515353342468245443394-3225CC175
B0/W148
n = 77		2233251735334246724444339378-3235CC22
2233251635334246724544331075-32-CC22
2233251734334246724544334737-32OrphanCC25
223325173533424672454433100-3227CC259
Other modern Beijing,
n = 25		2442333525444251733539239380-32-CC4 *2
2442333526444251733536231066-32-CC3 *2
2442333526444251733538231048-32-CC3 *2
2442343526444251733538239391-32-CC3 *9
Ancient Beijing, n = 82442313426444251733539231071-32-BL76
Note. Designations. The numerical profile of the strain shows the number of repeats in each of the 24 MIRU-VNTR loci in the following order: 12 loci MIRU, ETR-A, ETR-B, ETR-C, QUB-11b, QUB-26, QUB-4156, Mtub04, Mtub21, Mtub29, Mtub30, Mtub34, and Mtub39. CC is according to [2]. MIT refers to the SITVIT2 database. MLVA MtbC 15-9 refers to the code assigned to the MIRU-VNTRplus.org database. The MLVA MtbC15-9 type is defined by the combination of a type based on the 15 loci (MLVA MtbC15) of the discriminatory subset and a type based on the 9 auxiliary loci (MLVA MtbC9). * CC3 and CC4 [2] are polyphyletic groups not supported by robust WGS analysis.
Table
Table 4. Regional VNTR-based diversity of M. tuberculosis Beijing genotype strains.
Table 4. Regional VNTR-based diversity of M. tuberculosis Beijing genotype strains.
RegionNumber of IsolatesNumber of VNTR TypesNumber of ClustersCluster SizeNumber of Clustered Isolates (%)CRHGIShannon Index
Vologda512252–1834 (66.7)0.570.8522.48
Kaliningrad462462–1328 (60.9)0.480.9042.65
Karelia361833–921 (58.3)0.500.8812.55
Komi732382–2158 (79.5)0.680.8542.28
Murmansk351342–1526 (74.3)0.630.7902.04
Pskov452362–1028 (62.2)0.490.9212.62
CR—clustering rate; HGI—Hunter Gaston Index.
Table
Table 5. Drug resistance structure of the studied Beijing strains.
Table 5. Drug resistance structure of the studied Beijing strains.
Drug ResistanceNumber of Isolates and % of All of This Subtypep
B0/W148,
n = 77		Central Asian/Russian (Other Than CAO), n = 157Central Asian/Russian CAO, n = 19Other Modern Beijing, n = 25Ancient Beijing, n = 8
Susceptible. n = 69–67 (42.6)–14 (56.0)2 (25)<0.001
Monoresistant/polyresistant n = 4911 (14.3)30 (19.1)8 (42.1)6 (24.0)–
MDR. n = 14366 (85.7)60 (38.2)11 (57.9)5 (20.0)6 (75)
Note. Polyresistant strain is resistant to at least two drugs but not MDR.
Table
Table 6. Drug resistance of the main MIRU-VNTR clusters.
Table 6. Drug resistance of the main MIRU-VNTR clusters.
Beijing Clade24-MIRU-VNTR TypeNumber of Strains and % of All in This Typep
SusceptibleMonoresistant/PolyresistantMDR
B0/W148100-32 10 (16.9)49 (83.1)p 100-32 vs. 1076-32 = 0.003
p 100-32 vs. 9391-32 < 0.001
p 100-32 vs. 94-32 < 0.001
p 100-32 vs. 95-32 = 0.008
p 100-32 vs. 99-32 < 0.001
p 1065-32 vs. 9391-32 < 0.001
p 1065-32 vs. 94-32 = 0.048
p 1065-32 vs. 99-32 = 0.010
p 1071-32 vs. 99-32 = 0.026
p 94-32 vs. 99-32 = 0.039
B0/W1484737-32 5 (100)
C.A.R.94-3233 (44.0)9 (12.0)33 (44.0)
C.A.R.1065-32 2 (11.8)15 (88.2)
C.A.R.95-323 (25.0)3 (25.0)6 (50.0)
C.A.R.99-322 (33.3)4 (66.7)
C.A.R.1076-321 (20.0)3 (60.0)1 (20.0)
other9391-329 (100)
Ancient1071-32 6 (100)
C.A.R.—Central Asian Russian. p refers to the pairwise comparison of the genotypes. Only significant p values are shown (<0.05).
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Vyazovaya, A.; Gerasimova, A.; Mudarisova, R.; Terentieva, D.; Solovieva, N.; Zhuravlev, V.; Mokrousov, I. Genetic Diversity and Primary Drug Resistance of Mycobacterium tuberculosis Beijing Genotype Strains in Northwestern Russia. Microorganisms 2023, 11, 255. https://doi.org/10.3390/microorganisms11020255

AMA Style

Vyazovaya A, Gerasimova A, Mudarisova R, Terentieva D, Solovieva N, Zhuravlev V, Mokrousov I. Genetic Diversity and Primary Drug Resistance of Mycobacterium tuberculosis Beijing Genotype Strains in Northwestern Russia. Microorganisms. 2023; 11(2):255. https://doi.org/10.3390/microorganisms11020255

Chicago/Turabian Style

Vyazovaya, Anna, Alena Gerasimova, Regina Mudarisova, Daria Terentieva, Natalia Solovieva, Viacheslav Zhuravlev, and Igor Mokrousov. 2023. "Genetic Diversity and Primary Drug Resistance of Mycobacterium tuberculosis Beijing Genotype Strains in Northwestern Russia" Microorganisms 11, no. 2: 255. https://doi.org/10.3390/microorganisms11020255

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop